Evidence map›Paper›PMID 39541137›Full record

ArticleJAMA2025

The Carceral-Community Cascade and HCV Elimination.

Matthew J Akiyama, Tessa Bialek, Raphael Simonson

Abstract read
In one paragraph

Article in JAMA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Testing and Linkage to Hepatitis C Care From Alternative-to-Incarceration Programs: The Right Place? The Right Time?Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matthew J AkiyamaAlbert Einstein College of Medicine, Bronx, New York.
Tessa BialekCivil Rights Litigation Clearinghouse, University of Michigan Law School, Ann Arbor.
Raphael SimonsonNew York, New York.

Funding

Leveraging community health workers to improve SARS-CoV-2 testing and mitigation among criminal justice-involved individuals accessing a corrections-focused community-based organizationR01MD016744 · NIMHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Matthew Akiyama · 2021 to 2026
$3.5M
A Decentralized, Status neutral, Stakeholder-engaged, post-incarceration intervention for people with and at risk for HIVR33DA060627 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Matthew Akiyama · 2025 to 2026
$2.6M
Leveraging HCV Phylogenetic Networks to Prevent HIV and Other Blood Borne Infections Among People Who Inject DrugsDP2DA053730 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI AKIYAMA, MATTHEW · 2021 to 2021
$2.5M
A Decentralized, Status neutral, Stakeholder-engaged, post-incarceration intervention for people with and at risk for HIVR61DA060627 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI AKIYAMA, MATTHEW · 2024 to 2024
$963k
Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants LivingR00DA043011 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI AKIYAMA, MATTHEW · 2020 to 2022
$747k
Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE TrialK99DA043011 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI AKIYAMA, MATTHEW · 2017 to 2018
$369k
NIDA NIH HHS DP2 DA053730NIDA NIH HHS K99 DA043011NIDA NIH HHS R00 DA043011NIDA NIH HHS R33 DA060627NIDA NIH HHS R61 DA060627NIMHD NIH HHS R01 MD016744
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39541137
PMCPMC12818903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.